Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifaximin”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02376972
What this trial is testing

Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis

Who this might be right for
BACTERIAL VAGINOSIS
Alfasigma S.p.A. 392
Large-scale testing (Phase 3)Ended earlyNCT02240121
What this trial is testing

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

Who this might be right for
Crohn's Disease
Bausch Health Americas, Inc. 80
Testing effectiveness (Phase 2)WithdrawnNCT01359228
What this trial is testing

Rifaximin Treatment of Papulopustular Rosacea

Who this might be right for
Rosacea
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00269412
What this trial is testing

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Bausch Health Americas, Inc. 525
Post-approval studies (Phase 4)UnknownNCT04841980
What this trial is testing

Rifaximin Therapy vs Low FODMAP Diet In IBS

Who this might be right for
Irritable Bowel SyndromeSmall Intestinal Bacterial Overgrowth
University of Malaya 100
Testing effectiveness (Phase 2)Study completedNCT01466595
What this trial is testing

Rifaximin as a Modulator of Microbial Translocation and Immune Activation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 73
Post-approval studies (Phase 4)UnknownNCT02190357
What this trial is testing

Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial

Who this might be right for
Cirrhosis
Shanghai Changzheng Hospital 200
Early research (Phase 1)Study completedNCT01695174
What this trial is testing

A Pilot Study of Xifaxan to Treat Patients With PSC

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
Mayo Clinic 16
Large-scale testing (Phase 3)Study completedNCT01643083
What this trial is testing

Rifaximin for Functional Dyspepsia

Who this might be right for
Functional Dyspepsia
The University of Hong Kong 95
Not applicableStudy completedNCT02009592
What this trial is testing

Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients

Who this might be right for
Fatty LiverSteatohepatitis
Bezmialem Vakif University 42
Testing effectiveness (Phase 2)UnknownNCT00281502
What this trial is testing

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHepatitis CLiver Cirrhosis
Weill Medical College of Cornell University 50
Large-scale testing (Phase 3)UnknownNCT03962283
What this trial is testing

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Who this might be right for
Small Bowel DiseaseRifaximin
Chinese University of Hong Kong 78
Testing effectiveness (Phase 2)UnknownNCT04302402
What this trial is testing

Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment

Who this might be right for
Dyspepsia
Sanjay Gandhi Postgraduate Institute of Medical Sciences 132
Post-approval studies (Phase 4)Ended earlyNCT03818672
What this trial is testing

Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects

Who this might be right for
Severe Hepatic Impairment
Bausch Health Americas, Inc. 5
Post-approval studies (Phase 4)WithdrawnNCT00748904
What this trial is testing

Rifaximin Versus Lactulose in Renal Failure

Who this might be right for
Liver CirrhosisRenal Failure
Weill Medical College of Cornell University
Large-scale testing (Phase 3)Active Not RecruitingNCT05071716
What this trial is testing

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 524
Not applicableStudy completedNCT02488993
What this trial is testing

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)

Who this might be right for
Hepatic Encephalopathy
Norgine 389
Early research (Phase 1)Study completedNCT00743912
What this trial is testing

Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers

Who this might be right for
Pharmacokinetic
Bausch Health Americas, Inc. 24
Large-scale testing (Phase 3)Study completedNCT01543178
What this trial is testing

Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Bausch Health Americas, Inc. 2,583
Post-approval studies (Phase 4)Study completedNCT04736836
What this trial is testing

Microbial Resistance of Rifaximin in Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
National Hepatology & Tropical Medicine Research Institute 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation